335 related articles for article (PubMed ID: 23894862)
1. Pharmacogenetics and personalized treatment of type 2 diabetes.
Semiz S; Dujic T; Causevic A
Biochem Med (Zagreb); 2013; 23(2):154-71. PubMed ID: 23894862
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetic studies update in type 2 diabetes mellitus.
Singh S; Usman K; Banerjee M
World J Diabetes; 2016 Aug; 7(15):302-15. PubMed ID: 27555891
[TBL] [Abstract][Full Text] [Related]
3. Stratified medicine for the use of antidiabetic medication in treatment of type II diabetes and cancer: where do we go from here?
Emami-Riedmaier A; Schaeffeler E; Nies AT; Mörike K; Schwab M
J Intern Med; 2015 Feb; 277(2):235-247. PubMed ID: 25418285
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacogenetics of oral antidiabetic treatment].
Tkáč I
Vnitr Lek; 2016 Mar; 62(3):186-8. PubMed ID: 27180666
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of oral antidiabetic therapy.
Ordelheide AM; Hrabě de Angelis M; Häring HU; Staiger H
Pharmacogenomics; 2018 Apr; 19(6):577-587. PubMed ID: 29580198
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine.
Mannino GC; Andreozzi F; Sesti G
Diabetes Metab Res Rev; 2019 Mar; 35(3):e3109. PubMed ID: 30515958
[TBL] [Abstract][Full Text] [Related]
7. Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.
Mannino GC; Sesti G
Mol Diagn Ther; 2012 Oct; 16(5):285-302. PubMed ID: 23018631
[TBL] [Abstract][Full Text] [Related]
8. Precision medicine: The future in diabetes care?
Scheen AJ
Diabetes Res Clin Pract; 2016 Jul; 117():12-21. PubMed ID: 27329017
[TBL] [Abstract][Full Text] [Related]
9. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective.
Manolopoulos VG; Ragia G; Tavridou A
Pharmacogenomics; 2011 Aug; 12(8):1161-91. PubMed ID: 21843065
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of the Glucagon-like Peptide-1 Receptor Agonist Liraglutide: A Step Towards Personalized Type 2 Diabetes Management.
Kyriakidou A; Koufakis T; Goulis DG; Vasilopoulos Y; Zebekakis P; Kotsa K
Curr Pharm Des; 2021; 27(8):1025-1034. PubMed ID: 33272167
[TBL] [Abstract][Full Text] [Related]
12. Oral antidiabetic drug metabolism: pharmacogenomics and drug interactions.
Holstein A; Beil W
Expert Opin Drug Metab Toxicol; 2009 Mar; 5(3):225-41. PubMed ID: 19331589
[TBL] [Abstract][Full Text] [Related]
13. Current progress in pharmacogenomics of Type 2 diabetes: A systemic overview.
Guo Z; Priefer R
Diabetes Metab Syndr; 2021; 15(5):102239. PubMed ID: 34371302
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of Antidiabetic Drugs.
Srinivasan S; Yee SW; Giacomini KM
Adv Pharmacol; 2018; 83():361-389. PubMed ID: 29801583
[TBL] [Abstract][Full Text] [Related]
15. Drug interactions of clinical importance with antihyperglycaemic agents: an update.
Scheen AJ
Drug Saf; 2005; 28(7):601-31. PubMed ID: 15963007
[TBL] [Abstract][Full Text] [Related]
16. Understanding the Pathogenesis, Therapeutic Targets/Drug Action and Pharmacogenetics of Type 2 Diabetes: Is there a Future for Personalised Medicine?
Engwa GA; Nweke FN; Karngong GN; Afiukwa CA; Nwagu KE
Endocr Metab Immune Disord Drug Targets; 2020; 20(10):1569-1589. PubMed ID: 32334506
[TBL] [Abstract][Full Text] [Related]
17. Genetic and Phenotypic Factors Affecting Glycemic Response to Metformin Therapy in Patients with Type 2 Diabetes Mellitus.
Nasykhova YA; Barbitoff YA; Tonyan ZN; Danilova MM; Nevzorov IA; Komandresova TM; Mikhailova AA; Vasilieva TV; Glavnova OB; Yarmolinskaya MI; Sluchanko EI; Glotov AS
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893047
[TBL] [Abstract][Full Text] [Related]
18. Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance.
Kirchheiner J; Roots I; Goldammer M; Rosenkranz B; Brockmöller J
Clin Pharmacokinet; 2005; 44(12):1209-25. PubMed ID: 16372821
[TBL] [Abstract][Full Text] [Related]
19. Metformin transporter pharmacogenomics: insights into drug disposition-where are we now?
Chan P; Shao L; Tomlinson B; Zhang Y; Liu ZM
Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1149-1159. PubMed ID: 30375241
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacogenetics and potential application in personalized medicine.
Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
